MediciNova
MNOV
#10060
Rank
HK$0.51 B
Marketcap
HK$10.07
Share price
1.18%
Change (1 day)
-9.54%
Change (1 year)

EPS for MediciNova (MNOV)

EPS in 2026 (TTM): -HK$1.80

According to MediciNova's latest financial reports the company's current EPS (TTM) is -HK$1.80. In 2025 the company made an earnings per share (EPS) of -HK$1.88 a decrease over its 2024 EPS that were of -HK$1.80.

EPS history for MediciNova from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.80-4.29%
2025-HK$1.884.35%
2024-HK$1.8035.29%
2023-HK$1.33-41.38%
2022-HK$2.2738.1%
2021-HK$1.65-32.26%
2020-HK$2.433.33%
2019-HK$2.35-16.67%
2018-HK$2.8212.5%
2017-HK$2.51-3.03%
2016-HK$2.59-0%
2015-HK$2.59-13.16%
2014-HK$2.98100%
2013-HK$1.49-71.21%
2012-HK$5.17-45%
2011-HK$9.41-26.38%
2010-HK$12.78-2.98%
2009-HK$13.17-7.69%
2008-HK$14.27-56.25%
2007-HK$32.6118.18%
2006-HK$27.5922.22%
2005-HK$22.57-99.82%
2004-HK$12,4811182.05%
2003-HK$973.50-10.4%
2002-HK$1,087286.13%
2001-HK$281.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.15-2,382.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$242.13-13,530.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.52-961.10%๐Ÿ‡ซ๐Ÿ‡ท France
Titan Pharmaceuticals
TTNP
-HK$34.41 1,808.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
-HK$0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
HK$3.53-295.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel